ExcellGene SA
Joeri Kint is a seasoned professional in business development and sales within the biopharmaceutical industry, currently serving as Vice President of Global Business Development & Sales at ExcellGene SA since March 2020. Prior to this role, Joeri held key positions at Biotype Diagnostic GmbH, including Head of CDMO division for Molecular Diagnostics, and Manager of Business Development, where responsibilities encompassed strategic partnerships and product pipeline rationalization. Experience also includes leadership in process development for viral vaccines at MSD Animal Health and a project leader role during tenure at Intervet/Schering-Plough AH. Joeri's academic background features a PhD in Virology and Immunology, along with a Master's degree in Biotechnology from Wageningen University & Research.
ExcellGene SA
Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus). We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking. At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.